Indeed, while Cyclin D1 has been shown to be suppressed by PRMT5 inhibition in cancer cells (37), Cyclin D1 was unaffected by PRMT5 inhibitor treatment in untransformed Th cells, even though it is induced upon TCR stimulation (Figures 2A–C). This evidence concerns the gene PRMT5 and cancer.